Could a drug revive immune systems in the ICU?
NCT ID NCT06694740
First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times
Summary
This study tests whether a drug called interferon gamma can help intensive care patients whose immune systems have shut down after a severe injury or infection. The main goal is to see if it helps them spend more days alive and off a breathing machine. About 170 adults on ventilators with low immune markers will receive either the drug or a placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT PATIENTS ADMITTED TO INTENSIVE CARE WITH INITIAL SEVERITY (SOFA OF THE FIRST 24 HOURS POST-ADMISSION ≥ 6 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dr de Roquetaillade
RECRUITINGParis, France
-
Pr Dépret
RECRUITINGParis, France